Search Results - Alexandra Martinez-Roca
- Showing 1 - 9 results of 9
-
1
P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMET... by Carlos Jimenez-Vicente, Francesca Guijarro, Monica Lopez-Guerra, Ares Guardia-Torrelles, Alexandra Martínez Roca, Alex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Dolors Colomer, Marina Diaz-Beya, Jordi Esteve
Published in HemaSphere (2023-08-01)Get full text
Article -
2
PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS by Ares Guardia-Torrelles, Carlos Jimenez-Vicente, Alexandra Martínez Roca, Sandra Castaño-Díez, Helena Brillembourg, Francesca Guijarro, Àlex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Marina Diaz-Beya, Jordi Esteve, Beatriz Merchan
Published in HemaSphere (2023-08-01)Get full text
Article -
3
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program by Sonia Ruiz-Boy, Alexandra Pedraza, Marta Prat, Maria Queralt Salas, Esther Carcelero, Gisela Riu-Viladoms, María Suárez-Lledó, Inés Monge-Escartín, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Montserrat Rovira, Carmen Martínez, Cristina Gallego, Álvaro Urbano-Ispizua, Joan Sánchez, María Ángeles Marcos, Francesc Fernández-Avilés
Published in Pharmaceuticals (2023-12-01)Get full text
Article -
4
P1394: RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. by Valentín Ortiz-Maldonado, Nuria Martinez-Cibrian, Marta Español-Rego, Guillermo Muñoz-Sanchez, Sergio Navarro, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Eva Gine, Luis Gerardo Rodríguez Lobato, Alexandra Martínez Roca, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Carlos Fernandez de Larrea, Mariona Pascal, Jordi Esteve, Avaro Urbano Ispizua, Manel Juan, Julio Delgado
Published in HemaSphere (2023-08-01)Get full text
Article -
5
P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED/ REFRACTORY CD19+ NON-HODGKIN LYMPHOMA by Nuria Martinez-Cibrian, Valentín Ortiz-Maldonado, Marta Español-Rego, Daniel Benitez-Ribas, Joan Cid, Miquel Lozano, Sergio Navarro, Laura Magnano, Eva Gine, Juan Gonzalo Correa Saldarriaga, Pablo Mozas, Luis Gerardo Rodríguez Lobato, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Leticia Alserawan, Alexandra Martínez Roca, Armando Lopez-Guillermo, Avaro Urbano Ispizua, Manel Juan, Mariona Pascal, Julio Delgado
Published in HemaSphere (2023-08-01)Get full text
Article -
6
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia by Carlos Jiménez-Vicente, Iago Arribas, Helena Pomares, Guillermo Ramil, Sandra Castaño-Diez, Amanda Isabel Pérez-Valencia, Antonella Luciana Sturla, Mònica López-Guerra, Alexandra Martinez-Roca, Inés Zugasti, Francesca Guijarro, Albert Cortés-Bullich, Beatriz Merchán, Ana Triguero, Inés Monge, Albert Tuca, Guadalupe Oñate, Ana Garrido, Jorge Sierra, Montserrat Arnan, Jordi Esteve, Marina Díaz-Beyá, Spanish CETLAM Group
Published in Haematologica (2025-01-01)Get full text
Article -
7
The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to r... by Luis-Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Sandra Castaño-Díez, Alicia Palomino-Mosquera, Gonzalo Gutiérrez-García, Alexandra Pedraza, María Suárez-Lledó, Montserrat Rovira, Carmen Martínez, Carlos Fernández de Larrea, María-Teresa Cibeira, Laura Rosiñol, Ester Lozano, Pedro Marín, Joan Cid, Miquel Lozano, Ana Belén Moreno-Castaño, Marta Palomo, Maribel Díaz-Ricart, Cristina Gallego, Adelina Hernando, Susana Segura, Enric Carreras, Álvaro Urbano-Ispizua, Joan Bladé, Francesc Fernández-Avilés
Published in PLoS ONE (2020-01-01)Get full text
Article -
8
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the... by Carlos Jimenez-Vicente, Aina Cardus, Sandra Castaño-Diez, Guillermo Ramil, Sara Garcia-Avila, Lucia Gomez-Perez, Daniel Esteban, Iago Arribas, Antonella Lucia Sturla, Monica Lopez-Guerra, Alexandra Martinez-Roca, Albert Cortes-Bullich, Amanda Isabel Perez-Valencia, Ines Zugasti, Ines Monge, Esther Carcelero, Ferran Vall-Llovera, Susana Vives, Jorge Sierra, Josep Nomdedeu, Guadalupe Oñate, Ana Garrido, Marta Pratcorona, Helena Pomares, Montserrat Arnan, Francesca Guijarro, Marina Diaz-Beya, Jordi Esteve, on behalf of the Spanish CETLAM Group
Published in Blood Cancer Journal (2025-05-01)Get full text
Article -
9
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study by Ines Zugasti, Monica Lopez-Guerra, Sandra Castaño-Díez, Daniel Esteban, Alejandro Avendaño, Helena Pomares, Ana Perez, Sara García-Ávila, Irene Padilla Conejo, Cristina de la Fuente Montes, Alexandra Martínez-Roca, Beatriz Merchán, Carlos Jiménez-Vicente, Francesca Guijarro, Jose Ramón Álamo, Albert Cortes-Bullich, Victor Torrecillas, Lucia Mont, Esther Carcelero, Gisela Riu, Lurdes Zamora, Joan Bargay, Ana Triguero, Maria Suarez-Lledó, Maria Queralt Salas, Felix López-Cadenas, Fernando Ramos, Blanca Xicoy, David Valcárcel, Montserrat Arnan, Carmen Martínez, Montserrat Rovira, Francesc Fernández-Avilés, Maria Díez-Campelo, Jordi Esteve, Marina Díaz-Beyá
Published in Experimental Hematology & Oncology (2025-04-01)Get full text
Article
